Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.
Mort JF, Brighton D, DiBenedetto S, Wells L, Clark SM, Reid J, Patel I, Jackson C, Yelvington B, Miller R, Perciavalle M, Walsh K, Wolfe H, Locke SC, Zeidner JF, Duong VH, Reed DR, Dholaria B, LeBlanc TW, Keng M, Horton B, El Chaer F. Mort JF, et al. Among authors: duong vh. Eur J Haematol. 2024 Nov 27. doi: 10.1111/ejh.14354. Online ahead of print. Eur J Haematol. 2024. PMID: 39601208
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation.
Sanchez-Petitto G, Goloubeva O, Childress J, Iqbal T, Masur J, An M, Muhammad S, Lawson J, Li G, Barr B, Emadi A, Duong VH, Hardy NM, Rapoport AP, Baer MR, Niyongere S, Yared JA. Sanchez-Petitto G, et al. Among authors: duong vh. Acta Haematol. 2024 Aug 27:1-12. doi: 10.1159/000541131. Online ahead of print. Acta Haematol. 2024. PMID: 39191224
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.
Hoff FW, Blum WG, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Archer KJ, Patel PA, Collins RH, Baer MR, Duong VH, Arellano ML, Stock W, Odenike O, Redner RL, Kovacsovics T, Deininger MW, Zeidner JF, Olin RL, Smith CC, Foran JM, Schiller GJ, Curran EK, Koenig KL, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Byrd JC, Madanat YF. Hoff FW, et al. Among authors: duong vh. Blood Adv. 2024 Oct 22;8(20):5297-5305. doi: 10.1182/bloodadvances.2024013685. Blood Adv. 2024. PMID: 39110987 Free PMC article.
85 results